H.C. Wainwright Reiterates Buy Rating on Zenas Biopharma (ZBIO)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Oil slips but stays near six-month highs on Saudi attacks
| (NASDAQ: ZBIO) | Delayed: 26.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.87 | 52 Week High | $50.95 | |||
| Open | $26.87 | 52 Week Low | $18.06 | |||
| Day High | $26.87 | P/E | N/A | |||
| Day Low | $26.87 | EPS | $0.00 | |||
| Volume | 53,082 | |||||
